to a subject in need of this treatment an effective amount of such a thiourea compound as used herein the term u201c treating u201d refers to administering a thiourea compound to a subject that has hcv infection or has a symptom of hcv infection or has a predisposition toward hcv infection with the purpose to prevent cure heal alleviate relieve alter remedy ameliorate improve or affect the hcv infection the symptoms of the hcv infection or the predisposition toward the hcv infection the term u201c an effective amount u201d refers to the amount of the active agent that is required to confer the intended therapeutic effect in the subject effective amounts may vary as recognized by those skilled in the art depending on route of administration excipient usage and the possibility of co usage with other agents to practice the method provided in this application the above described pharmaceutical composition can be administered orally parenterally by inhalation spray topically rectally nasally buccally vaginally or via an implanted reservoir the term u201c parenteral u201d as used herein includes subcutaneous intracutaneous intravenous intramuscular intraarticular intraarterial intrasynovial intrasternal intrathecal intralesional and intracranial injection or infusion techniques a sterile injectable composition e g a sterile injectable aqueous or oleaginous suspension can be formulated according to techniques known in the art using suitable dispersing or wetting agents such as tween 80 and suspending agents the sterile injectable preparation can also be a sterile injectable solution or suspension in a non toxic parenterally acceptable diluent or solvent for example as a solution in 1 3.